Abstract
Platinum coordination complexes (PtCx) are potent against several types of cancer but are often nephrotoxic. With a view to developing a PtCx nephrotoxicity model, the toxicity of cisplatin (cDDP), transplatin (tDDP) and carboplatin (CBDCA) was studied in primary cultures of rabbit proximal tubule (RPT) cells and in the renal epithelial OK cell line. The cytotoxicity of these PtCx (10–3000 μM) was assessed after 24 h exposure of confluent monolayers in terms of LDH release; their effects at non-cytotoxic concentrations (1–1000 μM) on DNA and protein synthesis, glucose transport, marker enzymes and the total glutathione concentration were also determined, together with cellular platinum uptakes. The cytotoxicity ranking of the studied compounds differed for OK and RPT cells (cDDP>tDDP; cDDP>CBDCA and tDDP>cDDP; cDDP>CBDCA, respectively). Only results which were obtained in RPT cells corresponded to reported nephrotoxicity in vivo, making OK cells inappropriate for the study of PtCx nephrotoxicity in vitro. cDDP was about 10 times less cytotoxic for OK cells than for RPT cells because of lower cellular uptake. tDDP was unable markedly to inhibit biochemical and functional parameters in RPT cells below cytotoxic concentrations. At non-cytotoxic concentrations, cDDP and CBDCA depressed synthetic activity (mainly DNA) and, to a lesser extent, Na+-K+- ATPase activity and glucose transport in RPT cells. Total glutathione levels in RPT cells steadily increased during exposure to cDDP, tDDP and CBDCA, before the onset of cell death, arguing against an early role of glutathione depletion in PtCx toxicity. However, brush-border enzymes (γ-glutamyl transferase and alkaline phosphatase) and succinate dehydrogenase were insensitive to the action of either cDDP or CBDCA in RPT cells. On the basis of cytotoxicity and functional impairments, the toxicity of the three PtCx for RPT cells in vitro correlated with their reported nephrotoxicity in vivo, showing that RPT cells in primary culture are suitable for investigating the nephrotoxicity of PtCx.
Similar content being viewed by others
References
Anderson H, Wagstaff J, Crowther D, Swindell R, Lind MJ, McGregor J, Timms MS, Brown D, Palmer P (1988) Comparative toxicity of cisplatin, carboplatin (CBDCA) and iproplatin (CHIP) in combination with cyclophosphamide in patients with advanced epithelial ovarian cancer. Eur J Cancer Clin Oncol 24: 1471–1479
Balzer MA, Aggarwal SK (1986) An in vitro screening system for the nephrotoxicity of various platinum coordination complexes: a cytochemical study. Cancer Chemother Pharmacol 17: 209–217
Bergmeyer HU, Bernt E (1974) Lactate dehydrogenase UV-assay with pyruvate and NADH. In: Bergmeyer HU (ed) Methods of enzymatic analysis. Academic Press, New York, pp 574–579
Boogaard PJ, Zoeteweij JP, VanBerkel TJC, Van'TNoordende JM, Mulder GJ, Nagelkerke JF (1990) Primary culture of proximal tubular cells from normal rat kidney as an in vitro model to study mechanisms of nephrotoxicity. Biochem Pharmacol 39: 1335–1345
Bradford MM (1976) A rapid and sensitive method for quantification of microgram quantities of protein utilizing the principle of protein dye binding. Anal Biochem 72: 248–254
Campbell AB, Kaiman SM, Jacobs C (1983) Plasma platinum levels: relationship to cisplatin dose and nephrotoxicity. Cancer Treat Rep 67: 169–172
Choie DD, Del Campo AA, Guarino AM (1980) Subcellular localization of cis-diamminedichloroplatinum (II) in rat kidney and liver. Toxicol Appl Pharmacol 55: 245–252
Courjault F, Gerin B, Leroy D, Chevalier J, Toutain H (1991) Morphological and biochemical characterization of the opossum kidney cell line and primary cultures of rabbit proximal tubule cells in serumfree defined medium. Cell Biol Int Rep 15: 1225–1234
Dedon PC, Borch RF (1987) Characterization of the reactions of platinum antitumor agents with biologic and nonbiologic sulfur-containing nucleophiles. Biochem Pharmacol 36: 1955–1964
Dobyan DC, Levi J, Jacobs C, Kosek J, Weiner MW (1980) Mechanism of cisplatinum nephrotoxicity: II Morphologic observations. J Pharmacol Exp Ther 213: 551–556
Dumas M, D'Athis P, De Gislain C, Escousse A, Guerrin J, Autissier N (1985) Model independent pharmacokinetic study of cis-dichlorodi-ammineplatinum (II). Int J Clin Pharmacol Ther Toxicol 23: 430–433
Fichtinger-Schepman AMJ, Dijt FJ, DeJong WH, VanOosterom AT, Berends F (1988) In vivo cis-diamminedichloroplatinum (II)-DNA adduct formulation and removal as measured with immunochemical techniques. In: Nicolini M (ed) Platinum and other metal coordination compounds in cancer chemotherapy. Martinus Nijhoff, Boston, pp 33–46
Fillastre JP, Raguenez-Viotte G (1989) Cisplatin nephrotoxicity. Toxicol Lett 46: 163–175
Friedlander G, LeGrimellec C, Amiel C (1990) Increase in membrane fluidity modulates sodium-coupled uptakes and cyclic AMP synthesis by renal proximal tubular cells in primary cultures. Biochim Biophys Acta 1022: 1–7
Gordon JA, Gattone VH (1986) Mitochondrial alterations in cisplatin-induced acute renal failure. Am J Physiol 250: F991-F998
Griffith OW (1980) Determination of glutathione and glutathione disulfide using glutathione reductase and 2-vinylpyridine. Anal Biochem 106: 207–212
Halabe A, Wong NLM, Sutton RAL (1991) Effects of chronic cisplatin administration on phosphate and glucose transport by the renal brush border membrane. Nephron 57: 197–200
Hannemann J, Baumann K (1988) Cisplatin-induced lipid peroxydation and decrease of gluconeogenesis in the rat kidney cortex: different effects of antioxidants and radical scavengers. Toxicology 51: 119–132
Hannemann J, Baumann K (1990) Nephrotoxicity of cisplatin, carboplatin and transplatin. Arch Toxicol 64: 393–400
Harder HC, Rosenberg B (1970) Inhibitory effects of antitumor platinum compounds on DNA, RNA and protein synthesis in mammalian cells in vitro. Int J Cancer 6: 207–216
Harland SJ, Newell DR, Siddik ZH, Chadwick R, Calvert AH, Harrap KR (1984) Pharmacokinetics of cis-diammine-1,1-cyclobutane dicarboxylate platinum (II) in patients with normal and impaired renal function. Cancer Res 44: 1693–1697
Hjelle JT, Morin JP, Trouet A (1981) Analytical cell fractionation of isolated rabbit renal proximal tubules. Kidney Int 20: 71–77
Jones TW, Chopra S, Kaufman JS, Flamembaum W, Trump BF (1985) Cis-diamminedichloroplatinum (II)-induced acute renal failure in the rat: enzyme histochemical studies. Toxicol Pathol 13: 296–305
Klein J, Bentur Y, Cheung D, Moselhy G, Koren G (1991) Renal handling of cisplatin: interactions with organic anions and cations in the dog. Clin Invest Med 14: 389–394
Knox R, Friedlos F, Lydall DA, Roberts JJ (1986) Mechanism of cytotoxicity of anticancer platinum drugs: evidence that cis diamminedichloroplatinum (II) and cis-diammine(1,1-cyclobutanedicarboxylato)platinum (II) differ only in the kinetics of their interaction with DNA. Cancer Res 46: 1972–1979
Leonard BJ, Eccleston E, Jones D, Todd P, Walpole A (1971) Antileukaemic and nephrotoxic properties of platinum compounds. Nature 234: 43–45
Litterst CL (1984) Cisplatinum: a review, with special reference to cellular and molecular interactions. Agents Actions 15: 520–524
Los G, Verdegall E, Noteborn HP, Ruevekamp M, DeGraff A, Meesters EW, Huinink DTB, McVie JG (1991) Cellular pharmacokinetics of carboplatin and cisplatin in relation to their cytotoxic action. Biochem Pharmacol 42: 357–363
Lowry OH, Rosebrough NJ, Farr AL, Randall RJ (1951) Protein measurement with the folin phenol reagent. J Biol Chem 193: 265–275
McDonald BR, Kirmani S, Vasquez M, Mehta RL (1991) Acute renal failure associated with the use of intraperitoneal carboplatin: a report of two cases and review of the literature. Am J Med 90: 386–391
Mistry P, Merazga Y, Spargo DJ, Riley PA, McBrien DCH (1991) The effects of cisplatin on the concentration of protein thiols and glutathione in the rat kidney. Cancer Chemother Pharmacol 28: 277–282
Nosaka K, Nakada J, Endou H (1992) Cisplatin-induced alterations in renal structure, ammoniagenesis and gluconeogenesis of rats. Kidney Int 41: 73–79
Pennington RJ (1961) Biochemistry of dystrophic muscle. Mitochondrial succinate-tetrazolium reductase and adenosine triphosphatase. Biochem J 80: 649–654
Phelps JS, Gandolfi AJ, Brendel K, Dorr RT (1987) Cisplatin nephrotoxicity: in vitro studies with precision-cut rabbit renal cortical slices. Toxicol Appl Pharmacol 90: 501–512
Plooy ACM, VanDijk M, Lohman PHM (1984) Induction and repair of DNA cross-links in Chinese hamster ovary cells treated with various platinum coordination compounds in relation to platinum binding to DNA, cytotoxicity, mutagenicity and antitumor activity. Cancer Res 44: 2042–2051
Reed DJ, Beatty PW (1980) Biosynthesis and regulation of glutathione: toxicological implications. In: Hodgson E, Bend JR, Philipot RM (eds) Revue of Biochemical Toxicology, Vol. 2. Elsevier, New York, pp 213–241
Rose WC, Schurig JE (1985) Preclinical antitumor and toxicologic profile of carboplatin. Cancer Treat Rev 12: 1–19
Safirstein R, Miller P, Guttenplan JB (1984) Uptake and metabolism of cisplatin by rat kidney. Kidney Int 25: 753–758
Singh G, Koropatnick J (1988) Differential toxicity of cis and trans isomers of dichlorodiammineplatinum. J Biochem Toxicol 3: 223–233
Stewart DJ, Mikhael NZ, Nanji AA, Nair RC, Kacew S, Howard K, Hirte W, Maroun JA (1985) Renal and hepatic concentrations of platinum: relationship to cisplatin time, dose and nephrotoxicity. J Clin Oncol 3: 1251–1256
Tay LE, Bregman CL, Masters BA, Williams PD (1988). Effects of cis-diamminedichloroplatinum (II) on rabbit kidney in vivo and on rabbit renal proximal tubule cells in culture. Cancer Res 48: 2538–2543
Toutain H, Fillastre JP, Morin JP (1989) Preparative free flow electro-phoresis for the isolation of two populations of proximal cells from the rabbit kidney. Eur J Cell Biol 49: 274–280
Toutain H, Vauclin-Jacques N, Fillastre JP, Morin JP (1991) Biochemical, functional and morphological characterization of a primary culture of rabbit proximal tubule cells. Exp Cell Res 194: 9–18
Toutain H, Courjault F, Cordier A (1992) Renal proximal tubular cell culture: characterization and use in nephrotoxicology. In: Jolles G, Cordier A (eds) In vitro methods in toxicology. Academic Press, New York, pp 93–130
Uozumi J, Litterst CL (1985) The effect of cisplatin on renal ATPase activity in vivo and in vitro. Cancer Chemother Pharmacol 15: 93–96
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Courjault, F., Leroy, D., Coquery, I. et al. Platinum complex-induced dysfunction of cultured renal proximal tubule cells. Arch Toxicol 67, 338–346 (1993). https://doi.org/10.1007/BF01973705
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01973705